Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03973788 · ClinicalTrials.gov registry record · NA

Effects of Repetitive Transcranial Magnetic Stimulation on Pain Thresholds in Patients With Chronic Low Back Pain

A NA study, sponsored by Texas Woman's University.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT03973788 is a NA study that has completed, run by Texas Woman's University. The registered enrollment target is 40 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03973788, a NA study, has completed, sponsored by Texas Woman's University.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

Chronic low back pain (CLBP) is a common reason for which patients are treated with opioids. Because the misuse of prescription opioids has become a serious problem in the Uinted States, finding effective alternative non-pharmaceutical interventions for chronic pain management has become an urgent matter. A phenomenon termed central sensitization (i.e. mal-adaption of the brain) has been hypothesized to be an underlying mechanism for the development of chronic pain, leading to sensory hypersensitivity to extremal stimuli. Therefore, non-invasive brain stimulation, such as repetitive transcranial magnetic stimulation (rTMS) may be an effective intervention to regulate brain excitability, thus reducing chronic pain. However, research has shown inconclusive evidence regarding the rTMS effects on chronic pain reduction, partly due to the heterogeneity of participants in studies to date. Therefore, the primary purpose of this study is to investigate the immediate and short-term effects of rTMS on neurosensory changes (i.e., pain thresholds) in patients with CLBP. The secondary purpuse of the study is to explore the relationship between changes of cortical excitability (TMS parameters) and changes of pain thresholds after the rTMS intervention in patients with CLBP.

Interventions

  • PROCEDURE repetitive transcranial magnetic stimulation (rTMS)

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2019-07-01
Est. Completion 2022-01-13
Phase NA

Sponsor

Texas Woman's University

51 total trials

What the Registry Record Tells You About NCT03973788

The ClinicalTrials.gov registry entry for NCT03973788 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Woman's University, which has 51 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which repetitive transcranial magnetic stimulation (rTMS) is the first listed.

NCT03973788 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03973788 about?

NCT03973788 is a clinical study titled "Effects of Repetitive Transcranial Magnetic Stimulation on Pain Thresholds in Patients With Chronic Low Back Pain". Chronic low back pain (CLBP) is a common reason for which patients are treated with opioids. Because the misuse of prescription opioids has become a serious problem in the Uinted States, finding effective alternative non-pharmaceutical interventions for chronic pain management has become an urgent m...

What is the current status of trial NCT03973788?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2019-07-01. Estimated completion is 2022-01-13.

What interventions are being tested in trial NCT03973788?

The interventions under investigation include: repetitive transcranial magnetic stimulation (rTMS) (PROCEDURE).

Who is sponsoring clinical trial NCT03973788?

This trial is sponsored by Texas Woman's University, which has 51 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.